Navigation Links
NARSAD Researchers Identify Specific Genes and Family Traits Linked to Schizophrenia, Bipolar Disorder and Depression
Date:5/30/2008

tes. "When we understand how people respond to different treatments and why, we will be able to design more targeted therapies for depression."

Family Traits Provide Clues to Genes for Schizophrenia, Bipolar Disorder

It is also important to identify the endophenotypes -- traits associated with a clinical disorder -- that can serve as a roadmap for detecting disease-related genes. That is why Deborah L. Levy, Ph.D, associate professor of psychology in the Department of Psychiatry at Harvard Medical School and director of the Psychology Research Laboratory at McLean Hospital, is studying families to detect relatives who are carriers of the genes for schizophrenia and bipolar disorder, even though these individuals don't have the diseases themselves.

"One of the key issues in any genetic study is to distinguish individuals who are gene carriers from individuals who are not gene carriers," explains Dr. Levy. In single gene disorders, such as cystic fibrosis and Huntington's disease, 25 percent and 50 percent of family members, respectively, have the same illness. In contrast, only 6.5 percent of family members of people with schizophrenia actually have the illness, which means most relatives don't have symptoms of the illness but may still be gene carriers.

To find the relatives who are likely carriers of genes for schizophrenia and bipolar disorder, Dr. Levy and her colleagues have zeroed in on four discernable schizophrenia-related traits that occur in well family members at a much higher rate than schizophrenia itself: difficulty following a slow moving target with one's eyes, syntax errors or idiosyncratic use of language, subtle anomalies involving the midline of the face, and difficulty filtering out noises and other irrelevant stimuli (a condition known as sensory gating).

These traits, according to Dr. Levy, are much more common in families with schizophrenia. For example, idiosyncratic use of language (a trait similar to the
'/>"/>

SOURCE NARSAD
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures
2. Peregrine Researchers Present New Preclinical Data at AACR Annual Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab
3. Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women
4. Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells
5. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
6. Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention
7. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
8. Researchers Use Magnetism to Target Cells to Animal Arteries
9. Novel Mechanism for Long-Term Learning Identified by Carnegie Mellon Researchers
10. Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models
11. Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...G, Pa., Oct. 6 /- Genaera,C...om its second Phase 1,clinical trial of trodusquem...the treatment of type 2 diabetes and obesity. MSI-...lecular target that controls the function,of both ...se and decrease,appetite. In the study, MSI-1436 w...
(Date:10/6/2008)...erence Call Scheduled for 9:00 AM ET Today -, SEA...rporation (Nasdaq:,DNDN) announced today that it h...hase 3, randomized, double-blind, placebo-controll...ma Treatment, also known as D9902B),clinical trial...,investigational active cellular immunotherapy PRO...
(Date:10/6/2008)... /- Dendreon Corporation (N...nday, October 6, 2008 at 9:00 AM,ET (6:00 AM PT) t...s IMPACT,(IMmunotherapy for Prostate AdenoCarcinom...of PROVENGE(R) (sipuleucel-T), the Company,s inves...reatment of advanced prostate,cancer., Those i...
(Date:10/5/2008)...ed in New England Journal of Medicine reaffirm,wel...e of SPIRIVA(R),HandiHaler(R), RIDGEFIELD, Conn.,...he,UPLIFT (Understanding Potential Long-term Impac... SPIRIVA(R) HandiHaler(R) (tiotropium bromide,inha...ction for up to 4,years as measured by FEV(1) (p<0...
Breaking Medicine Technology:Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 2Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 3Dendreon Announces Interim Data From Phase 3 PROVENGE IMPACT Trial 4Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6RoundTable Healthcare Partners Closes Sale of MedAssist Holding Inc to Firstsource Solutions Limited 939 1RoundTable Healthcare Partners Closes Sale of MedAssist Holding Inc to Firstsource Solutions Limited 939 2RoundTable Healthcare Partners Closes Sale of MedAssist Holding Inc to Firstsource Solutions Limited 939 3Center for Poverty Research to study senior hunger in America 2387 1Center for Poverty Research to study senior hunger in America 2387 2Connecticut Catholic Conference Wrong to Allow Plan B in Catholic Hospitals 2384 1Connecticut Catholic Conference Wrong to Allow Plan B in Catholic Hospitals 2384 2American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification 28TAN 29 Act 2380 1American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification 28TAN 29 Act 2380 2
...e/ -- A nationally renowned,cancer researcher affi...nted a novel study design concept called a Complet...e new agent development.,Studies utilizing this de...work,s innovative Translational Oncology Program (...e trials in a community,setting. These types of tr...
...nted at American Society of,Clinical Oncology (ASC...Newswire-FirstCall/ -- Medarex, Inc.,and Bristol-M...ultiple clinical studies of ipilimumab (MDX-010), ...h advanced melanoma.,The results demonstrated an a...melanoma either as a monotherapy or in combination...
Other Medicine Technology:Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 2Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 3Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 4Study Shows Advantages of Complete Phase Ib Trial Over Separate,Phase I Trials 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 2Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 3Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 4Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 6Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 7
(Date:10/7/2008)...RNewswire-FirstCall/ -- Stallergenes S.A.,today an...greement with,Catalent for the promotion and distr...FLEX(R), co-developed and co-manufactured by Catal...sts of a syringe pre-filled with adrenaline, which....3 and 0.15 mg), in an,autoinjector device. The Me...
(Date:10/7/2008)...of asthma in a young child may well be more challe..., according to a review of research and clinical e... Indiana University School of Medicine and Riley H... issue of Clinical Pediatrics . , "Wheezing ca... Professor of Pediatrics at the IU School of Medic...
(Date:10/7/2008)...rial Specialties, Mfg. is pleased to announce the ...hese filters are exclusively available from Indust... push-to-connect style fittings integrated into th...ne filter offers versatility and customization for... (PRWEB) October 7, 2008 -- Exclusively availa...
(Date:10/6/2008)...fight against childhood obesity, researcher notes ... Three-quarters of middle schools have vending mac...new study finds. , The research demonstrates th...ls, and "that those vending machines don,t always ...y Virus, a registered dietitian with the Center fo...
Breaking Medicine News(10 mins):Health News:Stallergenes Partners With Catalent and the Medical House for Commercialization of Adrenaline Autoinjector in Europe 2Health News:Wheezing and asthma in young children 2Health News:Vending Machines Found in Most Middle Schools 2
...ol, 'in'? A new report by the American Medical As...of college girls and their wild (s) ways!// A sur...at breaking out of control and going really berser... Three out of four women seem to get drunk and use...
...he world have assembled in Glasgow and discussing ...ities. The conference reviewed methadone programme...h annual National Drug Treatment Conference. Drug ... disturbing when a11-year-old girl had admitted ta...
...ccal meningitis has claimed 21 lives and 369 other...national capital// during the past three months, t...n infection of the fluid in the spinal cord and th...brain. A full cure is possible if the disease is d...
...luenza or bird flu in Jammu and Kashmir is slowly ... start to leave for their summer// homes in Russia... Migratory Bird Reserve is located 28 km north of ... around 50,000 migratory birds there these days wa...
Other Medicine News:Health News:Meningitis Back in Delhi and 21 Dead 2Health News:Bird Flu Fears Recede As Migratory Birds Leave 2
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed.
The Neuroclip is designed for safe, quick, and stable fixation of cranial bone flaps. Application is simple with minimal instrumentation. The Neuroclip can be applied to the cranial bone flap while t
Lorenz 1.0 mm titanium system provides a rigid fixation alternative for areas with high palpability and prominent bone formation. These areas include the frontal bone and the areas surrounding the or
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery.
Medicine Products: